Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Death

• Use of Fibrin Sealant Patch for Vein Anastomosis During Deceased Donor Liver Transplantation- Randomized Clinical Trial
• Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)
• Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
• Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial
• Micophenolate Mofetil Versus Azathioprine in Myocarditis
• Personalised Risk scOre For Implantation of Defibrillators in Patients With Reduced LVEF≤35% and a Low Risk for Sudden Cardiac Death
• Personalised Risk scOre For Implantation of Defibrillators in Patients With Preserved LVEF>35% and a High Risk for Sudden Cardiac Death
• Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor
• Azithromycin-Prevention in Labor Use Study (A-PLUS)
• Rapid Reversal of CNS-Depressant Drug Effect Prior to Brain Death Determination
• Exploring Mechanisms and Morphology of QT Interval Prolongation
• A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant
• A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
• Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death
• Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death
• Efficacy of Melatonin in Decreasing the Incidence of Delirium in End of Life Patients
• Domperidone and Risk of Sudden Cardiac Death
• Medical Management of Late Intrauterine Death.
• Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney
• Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome
• Pilot Study of Sedation With Propofol in Refractory Pains Due to Care in Palliative Care Unit
• Thymoglobulin in Cadaver Donor
• The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon
• An Observational Study to Assess the Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Users of Proton Pump Inhibitors, and Users of Metoclopramide
• Heart Rate Response to Regadenoson and Sudden Cardiac Death
• Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death
• Thymoglobulin Induction in Kidney Transplant Recipients
• Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
• Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant
• Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
• Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction
• Protective Effect of N-acetylcysteine on Early Outcomes of Deceased Renal Transplant
• Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone
• Impact of N-Acetylcysteine on Oxidative Stress and Renal Function in Deceased Kidney Transplant Recipients
• Nicorandil Study to Reduce Cardiac Death After Percutaneous Coronary Intervention (PCI) in Hemodialysis Patients
• Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker
• Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death
• Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease
• Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
• "Death Rattle" - A Double Blind, Randomly Controlled, Crossover Trial
• Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients
• OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction
• Protective Effect of EPA on Cardiovascular Events
• Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)